Tesamorelin

Pituitary GH/IGF-1 signaling, body composition, and liver-metabolism research

Stabilized GHRH analog

Tesamorelin is an FDA-approved active ingredient in Egrifta products for a specific HIV-lipodystrophy indication; Apex material is RUO and is not the approved drug product

Overview

Tesamorelin is a synthetic growth-hormone-releasing hormone analog modified to improve stability. It activates pituitary GHRH receptors, increasing endogenous growth-hormone release and downstream IGF-1 signaling. FDA-approved tesamorelin products are indicated for reduction of excess abdominal fat in adults with HIV and lipodystrophy. Research has also examined visceral adipose tissue, liver fat, body composition, and metabolic endpoints. Any Apex page should clearly separate the approved branded drug from Apex research material.

How it works

checkCreated with Sketch.

GHRH receptor activation: Stimulates pituitary release of endogenous growth hormone.

checkCreated with Sketch.

GH/IGF-1 axis: Downstream IGF-1 signaling provides a measurable endocrine response.

checkCreated with Sketch.

Adipose and hepatic metabolism: Clinical studies have evaluated visceral fat and liver-related metabolic endpoints.

Research areas

checkCreated with Sketch.

HIV-associated lipodystrophy

checkCreated with Sketch.

Visceral adipose tissue

checkCreated with Sketch.

Liver-fat research

checkCreated with Sketch.

GH/IGF-1 physiology

Research / study context

one

Randomized HIV-lipodystrophy trials: Clinical studies measured visceral adipose tissue, body composition, IGF-1, and safety.

two

Liver-fat studies: Research has evaluated hepatic fat and fibrosis-related markers in selected populations.

Key research findings

checkCreated with Sketch.

Tesamorelin has strong human evidence for its approved indication.

checkCreated with Sketch.

Evidence outside that indication varies and should be described as research.

checkCreated with Sketch.

Apex material must not be represented as Egrifta or an FDA-approved substitute.

Scientific reference starter set

one

Peptide Education Hub: Tesamorelin profile

two

FDA prescribing information: Egrifta SV/WR

three

PubMed search: tesamorelin visceral adipose HIV liver fat

Research material

View available specifications and batch documentation in the Apex catalog.

Important

For research use only. Not for human consumption. This profile is educational and does not provide treatment or personal-use instructions.